Abeona Therapeutics (ABEO) Tops Q3 EPS by 5c

Abeona Therapeutics (NASDAQ: ABEO) reported Q3 EPS of ($0.48), $0.05 better than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Incyte settles CMS lawsuit over Opzelura Medicaid rebate rules
• AeroVironment restates quarterly financials, citing $89M goodwill error